WPRIM Management System> DCMS> Translational and Clinical Pharmacology> 2020> 28> 1

Volume: 28 Issue: 1

1. Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects Page:55—65
2. Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjects Page:43—54
3. Survey of physicians' views on the clinical implementation of pharmacogenomics-based personalized therapy Page:34—42
4. Possibility of pharmacokinetic drug interaction between a DPP-4 inhibitor and a SGLT2 inhibitor Page:17—33
5. Complex influences of gut microbiome metabolism on various drug responses Page:7—16
6. What is the optimal fit-for-purpose design in an oncology first-in-human trial?: 3+3 vs. Bayesian Logistic Regression Model Page:1—6

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.